Cargando…

CYP2B618 is associated with nevirpine hypersensitivity independently of HLA-C04:01 in a Malawian HIV population

Detalles Bibliográficos
Autores principales:	Carr, Daniel, Chaponda, Mas, Castro, Elena Cornejo, Jorgensen, Andrea, Khoo, Saye, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127538/ http://dx.doi.org/10.1186/2045-7022-4-S3-P126

Ejemplares similares

CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations
por: Carr, Daniel F., et al.
Publicado: (2014)

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
por: Carr, Daniel F., et al.
Publicado: (2013)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Abs No: HLA-A*31:01 positive hypersensitive patient
por: Lichtenfels, Maike, et al.
Publicado: (2014)

Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi
por: Dickinson, Laura, et al.
Publicado: (2014)

Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010)

The HLA-A*31:01 allele: influence on carbamazepine treatment
por: Yip, Vincent Lai Ming, et al.
Publicado: (2017)

Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background
por: Stasiak, Magdalena, et al.
Publicado: (2020)

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
por: Pratoomwun, Jirawat, et al.
Publicado: (2021)

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population
por: Carr, Daniel F., et al.
Publicado: (2017)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

The effect of HLA-DRB1*04:01 on a mouse model of atherosclerosis
por: Blackler, Garth, et al.
Publicado: (2023)

Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01
por: Gardner, Joshua, et al.
Publicado: (2022)

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
por: Lewis, Joseph M., et al.
Publicado: (2016)

MALE SEX, HLA-C*04:01 AND COVID-19: A RISKY CONSTELLATION
por: Suwalski, Phillip, et al.
Publicado: (2022)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
por: Weiner, January, et al.
Publicado: (2021)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Characterization of Drug-Specific CD4(+) T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2023)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease
por: Oka, Shomi, et al.
Publicado: (2022)

Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis
por: Nightingale, Sam, et al.
Publicado: (2016)

Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study
por: McCallum, Andrew D., et al.
Publicado: (2016)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
por: Zhang, J. E., et al.
Publicado: (2017)

HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023)

Continuation of Solicitation for the Office of Science Financial Assistance Program - Notice DE-FG01-04ER04-01
Publicado: (2003)

LHC Statistics for the Period 01.01.1995 - 30.04.2003
Publicado: (2003)

LHC Statistics for the Period 01.01.1995 - 30.04.2004
Publicado: (2004)

LHC Statistics for the Period 01.01.1995 - 20.04.2005
Publicado: (2005)

Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity
por: Metushi, Imir G., et al.
Publicado: (2015)

Identification of the novel HLA‐B*51:01:01:78 allele and confirmation of extended sequence of B*18:01:26
por: Ulrich, Silvia, et al.
Publicado: (2022)

Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
por: Ogese, Monday O, et al.
Publicado: (2021)

Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis
por: Sloan, Derek J., et al.
Publicado: (2017)

LHC Procurement Statistics for the Period 01.01.1995-20.04.2007
Publicado: (2007)

Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care
por: De Spiegelaere, Ward, et al.
Publicado: (2015)

Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
por: Krismawati, Hana, et al.
Publicado: (2020)

In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
por: Larid, Guillaume, et al.
Publicado: (2021)

Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population
por: John, Shobana, et al.
Publicado: (2021)

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
por: Small, Catherine Butkus, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8mgmqnp8urjr29c6qi7rp1cuvs